产品标题 产品货号 产品规格 厂家
CD99 molecule-like 2 (CD99L2), transcript variant 4 from ORIGENE TECHNOLOGIESLY432656100 ugORIGENE TECHNOLOGIES
CD300 molecule-like family member b (CD300LB) from ORIGENE TECHNOLOGIESLY406296100 ugORIGENE TECHNOLOGIES
CD300 molecule-like family member d (CD300LD) from ORIGENE TECHNOLOGIESLY426525100 ugORIGENE TECHNOLOGIES
CD300 molecule-like family member f (CD300LF) from ORIGENE TECHNOLOGIESLY408391100 ugORIGENE TECHNOLOGIES
CD300 molecule-like family member g (CD300LG), transcript variant 1 from ORIGENE TECHNOLOGIESLY407998100 ugORIGENE TECHNOLOGIES
CD300 molecule-like family member g (CD300LG), transcript variant 3 from ORIGENE TECHNOLOGIESLY432805100 ugORIGENE TECHNOLOGIES
CD300 molecule-like family member g (CD300LG), transcript variant 4 from ORIGENE TECHNOLOGIESLY432858100 ugORIGENE TECHNOLOGIES
CD74 molecule, major histocompatibility complex, class II invariant chain (CD74), transcript variant 1 from ORIGENE TECHNOLOGIESLY422595100 ugORIGENE TECHNOLOGIES
CD74 molecule, major histocompatibility complex, class II invariant chain (CD74), transcript variant 2 from ORIGENE TECHNOLOGIESLY429196100 ugORIGENE TECHNOLOGIES
CD74 molecule, major histocompatibility complex, class II invariant chain (CD74), transcript variant 3 from ORIGENE TECHNOLOGIESLY422594100 ugORIGENE TECHNOLOGIES
CD74 molecule, major histocompatibility complex, class II invariant chain (CD74), transcript variant 2 from ORIGENE TECHNOLOGIESLY418040100 ugORIGENE TECHNOLOGIES
CD244 molecule, natural killer cell receptor 2B4 (CD244), transcript variant 1 from ORIGENE TECHNOLOGIESLY413990100 ugORIGENE TECHNOLOGIES
CD244 molecule, natural killer cell receptor 2B4 (CD244), transcript variant 2 from ORIGENE TECHNOLOGIESLY432954100 ugORIGENE TECHNOLOGIES
CD151 molecule (Raph blood group) (CD151), transcript variant 1 from ORIGENE TECHNOLOGIESLY418042100 ugORIGENE TECHNOLOGIES
CD151 molecule (Raph blood group) (CD151), transcript variant 2 from ORIGENE TECHNOLOGIESLY408328100 ugORIGENE TECHNOLOGIES
CD151 molecule (Raph blood group) (CD151), transcript variant 2 from ORIGENE TECHNOLOGIESLY430084100 ugORIGENE TECHNOLOGIES
CD151 molecule (Raph blood group) (CD151), transcript variant 5 from ORIGENE TECHNOLOGIESLY422059100 ugORIGENE TECHNOLOGIES
CD151 molecule (Raph blood group) (CD151), transcript variant 5 from ORIGENE TECHNOLOGIESLY425638100 ugORIGENE TECHNOLOGIES
CD164 molecule, sialomucin (CD164), transcript variant 1 from ORIGENE TECHNOLOGIESLY416885100 ugORIGENE TECHNOLOGIES
CD36 molecule (thrombospondin receptor) (CD36), transcript variant 1 from ORIGENE TECHNOLOGIESLY424373100 ugORIGENE TECHNOLOGIES
CD36 molecule (thrombospondin receptor) (CD36), transcript variant 2 from ORIGENE TECHNOLOGIESLY425033100 ugORIGENE TECHNOLOGIES
Human actinin, alpha 1 (ACTN1), transcript variant 2 from ORIGENE TECHNOLOGIESTP30492420 ugORIGENE TECHNOLOGIES
Human actin-like 6A (ACTL6A), transcript variant 1 from ORIGENE TECHNOLOGIESTP31797720 ugORIGENE TECHNOLOGIES
Human actin-like 7B (ACTL7B) from ORIGENE TECHNOLOGIESTP30747420 ugORIGENE TECHNOLOGIES
Human actin related protein 2/3 complex, subunit 1A, 41kDa (ARPC1A) from ORIGENE TECHNOLOGIESTP30805320 ugORIGENE TECHNOLOGIES
Human FtsJ methyltransferase domain containing 2 (FTSJD2) from ORIGENE TECHNOLOGIESTP30576220 ugORIGENE TECHNOLOGIES
DLX4 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN2021871 kitORIGENE TECHNOLOGIES
DLX4 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN202187BN1 kitORIGENE TECHNOLOGIES
DLX4 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN202187LP1 kitORIGENE TECHNOLOGIES
DLX4 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN202187RB1 kitORIGENE TECHNOLOGIES
DLX1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN2068951 kitORIGENE TECHNOLOGIES
DLX1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN206895BN1 kitORIGENE TECHNOLOGIES
DLX1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN206895LP1 kitORIGENE TECHNOLOGIES
DLX1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN206895RB1 kitORIGENE TECHNOLOGIES
DLX4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4021871 kitORIGENE TECHNOLOGIES
DLX5 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4025251 kitORIGENE TECHNOLOGIES
DLX3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4057951 kitORIGENE TECHNOLOGIES
DLX6 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4124941 kitORIGENE TECHNOLOGIES
Dlx1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5046241 kitORIGENE TECHNOLOGIES
Dlx2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5046251 kitORIGENE TECHNOLOGIES
Dlx3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5046261 kitORIGENE TECHNOLOGIES
DLX2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4075451 kitORIGENE TECHNOLOGIES
Dlx5 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5046281 kitORIGENE TECHNOLOGIES
DLX1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4068951 kitORIGENE TECHNOLOGIES
Dlx4 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5046271 kitORIGENE TECHNOLOGIES
Dlx6 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5046291 kitORIGENE TECHNOLOGIES
Human related RAS viral (r-ras) oncogene homolog (RRAS) from ORIGENE TECHNOLOGIESTP30482020 ugORIGENE TECHNOLOGIES
Human related RAS viral (r-ras) oncogene homolog 2 (RRAS2), transcript variant 1 from ORIGENE TECHNOLOGIESTP30459120 ugORIGENE TECHNOLOGIES
Slc5a4b - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5161611 kitORIGENE TECHNOLOGIES
Slc6a20b - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5161781 kitORIGENE TECHNOLOGIES
 |< < 5941 5942 5943 5944 5945 5946 5947 5948 5949 > >| 第 5947/6274 页